Correction: Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infection - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Association of Fecal Calprotectin Levels with Disease Severity and the Hypervirulent Ribotype 027 Strain in Clostridium difficile Infection Patients

  • By

  • Avi Peretz

  • Linda Tkhawkho

  • Nina Pastukh

  • Diana Brodsky

  • Chen Namimi-Halevi

  • Orna Nitzan

  • August 31, 2026

Share

Correction: Association of Fecal Calprotectin Levels with Disease Severity

Overview

This correction notice addresses the misrepresentation of authors' names in the original article regarding fecal calprotectin levels and Clostridium difficile infection.

Background

Fecal calprotectin is a biomarker used to assess colonic inflammation. Its role in Clostridium difficile infection (CDI) has been investigated. The hypervirulent ribotype 027 strain has been associated with more severe disease outcomes.

Data Highlights

No numerical or trial data is presented in this correction notice.

Key Findings

  • The original article incorrectly presented the authors' names.
  • Correct attribution of authorship is now provided.
  • Hypervirulent ribotype 027 strain is linked to higher severity in CDI cases.
  • Fecal calprotectin is recognized as a sensitive biomarker for colonic inflammation.

Clinical Implications

Accurate authorship is essential for the integrity of scientific literature.

Conclusion

This correction ensures proper authorship attribution.

Related Resources & Content

  1. BMC Infectious Diseases, 2016 -- Correction: Association of Fecal Calprotectin Levels with Disease Severity
  2. Journal of Crohn's and Colitis — Fecal Calprotectin Diagnostic Level Gradient Along the Small Bowel in Patients With Crohn’s Disease
  3. Frontiers in Pediatrics — Correction: Incidence of Clostridium difficile infection and enteric pathogens in children with inflammatory bowel disease presenting with disease exacerbation
  4. Frontiers in Pediatrics — Baseline gut microbiome features associated with fecal calprotectin response to exclusive enteral nutrition in pediatric Crohn’s disease
  5. The Journal of Infectious Diseases — The Role of Gut Microbiota and Butyrate in Distinguishing Clostridioides difficile Colonization from Infection in Pediatric Patients
  6. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults | Clinical Infectious Diseases | Oxford Academic
  7. Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infection | BMC Infectious Diseases | Springer Nature Link
  8. Strain and the Clinical Outcome of Clostridioides difficile Infection: A Meta-analysis | Open Forum Infectious Diseases | Oxford Academic

Original Source(s)

Correction: Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infection

  • by Avi Peretz, Linda Tkhawkho, Nina Pastukh, Diana Brodsky, Chen Namimi-Halevi, Orna Nitzan

  • August 31, 2026

Related Content

Medical Oddities: When Men Face Catcalling

Cooking, catcalling, and colon swaps—medicine keeps things interesting.

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.